Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression
about
Nanoparticle-mediated drug delivery for treating melanomaMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersStem cells and targeted approaches to melanoma curePathways and therapeutic targets in melanomaABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuitPhylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.Chromatin barcodes as biomarkers for melanoma.Understanding melanoma stem cellsEstablished and Emerging Biomarkers in Cutaneous Malignant Melanoma.Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.Change in number and size of circulating tumor cells with high telomerase activity during treatment of patients with gastric cancer.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring.Melanoma biomolecules: independently identified but functionally intertwined.Why is melanoma so metastatic?Prognostic and predictive biomarkers in melanoma: an update.Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Metastatic pathways in patients with cutaneous melanoma.Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.Melanoma antigens are biomarkers for ipilimumab response.Expression of Multidrug Resistance Transporter ABCB5 in a Murine Model of Human Conjunctival Melanoma.Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.Circulating melanoma cells: scoping the targetIsolation of Circulating Melanoma Cells.Blood MUC-18/MCAM expression in patients with melanoma: a suitable marker of poor outcome.PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.Is quantitative real time polymerase chain reaction MCAM transcript assay really suitable for prognostic and predictive management of melanoma patients?Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
P2860
Q26798379-32C1DE52-5859-466F-B90F-F29634EB5CC5Q26822406-8ABC473D-EE1D-41B6-81A8-EADC6055DA57Q26825014-30F07C7E-BE9A-4581-A4F2-CC58AB2358F0Q26865736-46D87C1A-8B72-4D88-9207-ECDBF6C9EAFAQ28242049-ECCD6BB7-A337-46EB-B445-028A16E63DD5Q30403025-408B9BD4-12A3-4C4E-BAD2-EC46C3316B2AQ33935453-380DD2AA-1A92-432E-BAB6-386F8DD6FF6DQ34293596-953E5720-E6F6-4DEF-A0A1-68CF742B910AQ34419273-AC65FB93-DB97-4899-9A49-B09A3B1A3A37Q36292299-1A4CEE36-C3AF-4E83-8C06-E67BC525D3EAQ37069223-F8C45BFE-4E50-414B-B965-0FB289B83D42Q37130096-1D2697FB-CAF9-416F-8309-C706E2282C2FQ37255590-D98F9CEC-2526-4480-BE72-D4263E820466Q37582403-81282BFF-B67F-4F23-AC30-3FEEF2E02584Q37615286-4990E186-5D4D-417B-BA1D-5D760C7D0F46Q38091649-C442EA5B-6263-4DAD-8C36-A2F0A57DD2E2Q38143977-CE756A66-BC62-4D72-A4D6-9C360EE899B2Q38150869-9499BA00-505F-40C8-A31A-1C98C11AE894Q38653619-0828D20A-203A-4327-8288-C49FD5B0CE76Q38770774-17E50837-07EC-47E7-950A-2DEEEB801DFAQ39024316-27F9024E-34F2-4A9F-A5F8-FFB6609E1261Q39172101-6DC7D337-C6DC-49E4-AA8F-B86420C92E5CQ39457456-144EC125-D3C1-4812-96D2-93AF71C821B8Q40399058-C49E9C71-25CE-42DD-B9A0-0B702CE6D073Q42253058-AFA77201-B9A6-47D3-9633-A074DB742347Q42550053-1B226A76-5E72-4500-B802-34EA8D3AEC28Q42754442-4FC91BC0-946E-4557-9E71-9CE47600998BQ46095671-F680DE02-4742-412B-B31F-4F61E308F34DQ47120556-7DBD26F8-B8BC-411C-887F-F284CA0F8082Q54107810-C6129AFC-F153-4E9F-90BB-99C501C62B6CQ54228755-DD8A4B8D-64EE-4A81-BABC-7CEB15866C57Q55421307-4873F8C5-E4BD-43AD-A4D1-B696DD5C1523
P2860
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Markers of circulating tumour ...... ase recurrence and progression
@ast
Markers of circulating tumour ...... ase recurrence and progression
@en
type
label
Markers of circulating tumour ...... ase recurrence and progression
@ast
Markers of circulating tumour ...... ase recurrence and progression
@en
prefLabel
Markers of circulating tumour ...... ase recurrence and progression
@ast
Markers of circulating tumour ...... ase recurrence and progression
@en
P2093
P2860
P50
P356
P1476
Markers of circulating tumour ...... ase recurrence and progression
@en
P2093
L Monshizadeh
M Millward
P Kumarasinghe
P2860
P356
10.1111/BJD.12057
P407
P577
2012-11-15T00:00:00Z